A Systematic Exploration of the Interactions Between Bacterial Effector Proteins and Host Cell Membranes

Overview

Journal Nat Commun

Specialty Biology

Date 2017 Sep 16

PMID 28912547

Citations 35

Authors

Bethany A Weigele

Robert C Orchard

Alyssa Jimenez

Gregory W Cox

Neal M Alto

Affiliations

Soon will be listed here.

Abstract

Membrane-bound organelles serve as platforms for the assembly of multi-protein complexes that function as hubs of signal transduction in eukaryotic cells. Microbial pathogens have evolved virulence factors that reprogram these host signaling responses, but the underlying molecular mechanisms are poorly understood. Here we test the ability of ~200 type III and type IV effector proteins from six Gram-negative bacterial species to interact with the eukaryotic plasma membrane and intracellular organelles. We show that over 30% of the effectors localize to yeast and mammalian cell membranes, including a subset of previously uncharacterized Legionella effectors that appear to be able to regulate yeast vacuolar fusion. A combined genetic, cellular, and biochemical approach supports that some of the tested bacterial effectors can bind to membrane phospholipids and may regulate membrane trafficking. Finally, we show that the type III effector IpgB1 from Shigella flexneri may bind to acidic phospholipids and regulate actin filament dynamics.Microbial pathogens secrete effector proteins into host cells to affect cellular functions. Here, the authors use a yeast-based screen to study around 200 effectors from six bacterial species, showing that over 30% of them interact with the eukaryotic plasma membrane or intracellular organelles.

Citing Articles

The T4bSS of Legionella features a two-step secretion pathway with an inner membrane intermediate for secretion of transmembrane effectors.

Malmsheimer S, Grin I, Bohn E, Franz-Wachtel M, Macek B, Sahr T PLoS Pathog. 2024; 20(11):e1012118.

PMID: 39546547 PMC: 11602083. DOI: 10.1371/journal.ppat.1012118.

Anchorage of bacterial effector at plasma membrane via selective phosphatidic acid binding to modulate host cell signaling.

Wang M, Guan Q, Wang C, Hu L, Hu X, Xu M PLoS Pathog. 2024; 20(11):e1012694.

PMID: 39531410 PMC: 11556746. DOI: 10.1371/journal.ppat.1012694.

Serum Levels of Arachidonic Acid, Interleukin-6, and C-Reactive Protein as Potential Indicators of Pulmonary Viral Infections: Comparative Analysis of Influenza A, Respiratory Syncytial Virus Infection, and COVID-19.

Iftimie S, Gabaldo-Barrios X, Penades-Nadal J, Canela-Capdevila M, Pinana R, Jimenez-Franco A Viruses. 2024; 16(7).

PMID: 39066228 PMC: 11281451. DOI: 10.3390/v16071065.

Cell-selective proteomics reveal novel effectors secreted by an obligate intracellular bacterial pathogen.

Sanderlin A, Kurka Margolis H, Meyer A, Lamason R Nat Commun. 2024; 15(1):6073.

PMID: 39025857 PMC: 11258249. DOI: 10.1038/s41467-024-50493-9.

Unravelling bacterial virulence factors in yeast: From identification to the elucidation of their mechanisms of action.

Wong Z, Ong E Arch Microbiol. 2024; 206(7):303.

PMID: 38878203 DOI: 10.1007/s00203-024-04023-2.

References

Grecco H, Schmick M, Bastiaens P . Signaling from the living plasma membrane. Cell. 2011; 144(6):897-909. DOI: 10.1016/j.cell.2011.01.029. View

Buchwald G, Friebel A, Galan J, Hardt W, Wittinghofer A, Scheffzek K . Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 2002; 21(13):3286-95. PMC: 126081. DOI: 10.1093/emboj/cdf329. View

Kollmann M, Lovdok L, Bartholome K, Timmer J, Sourjik V . Design principles of a bacterial signalling network. Nature. 2005; 438(7067):504-7. DOI: 10.1038/nature04228. View

Lemmon M . Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol. 2008; 9(2):99-111. DOI: 10.1038/nrm2328. View

Cui J, Shao F . Biochemistry and cell signaling taught by bacterial effectors. Trends Biochem Sci. 2011; 36(10):532-40. DOI: 10.1016/j.tibs.2011.07.003. View

Handa Y, Suzuki M, Ohya K, Iwai H, Ishijima N, Koleske A . Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat Cell Biol. 2006; 9(1):121-8. DOI: 10.1038/ncb1526. View

Stefan C, Manford A, Baird D, Yamada-Hanff J, Mao Y, Emr S . Osh proteins regulate phosphoinositide metabolism at ER-plasma membrane contact sites. Cell. 2011; 144(3):389-401. DOI: 10.1016/j.cell.2010.12.034. View

Aronheim A, Zandi E, Hennemann H, Elledge S, Karin M . Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol. 1997; 17(6):3094-102. PMC: 232162. DOI: 10.1128/MCB.17.6.3094. View

Tegtmeyer N, Wessler S, Backert S . Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 2011; 278(8):1190-202. PMC: 3070773. DOI: 10.1111/j.1742-4658.2011.08035.x. View

10.

Gietz R, Schiestl R, Willems A, Woods R . Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast. 1995; 11(4):355-60. DOI: 10.1002/yea.320110408. View

11.

Schlumberger M, Muller A, Ehrbar K, Winnen B, Duss I, Stecher B . Real-time imaging of type III secretion: Salmonella SipA injection into host cells. Proc Natl Acad Sci U S A. 2005; 102(35):12548-53. PMC: 1194920. DOI: 10.1073/pnas.0503407102. View

12.

Russell A, Peterson S, Mougous J . Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol. 2014; 12(2):137-48. PMC: 4256078. DOI: 10.1038/nrmicro3185. View

13.

Franke T, Kaplan D, Cantley L, Toker A . Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 1997; 275(5300):665-8. DOI: 10.1126/science.275.5300.665. View

14.

Gillooly D, Morrow I, Lindsay M, Gould R, Bryant N, Gaullier J . Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 2000; 19(17):4577-88. PMC: 302054. DOI: 10.1093/emboj/19.17.4577. View

15.

Wang L, Seeley E, Wickner W, Merz A . Vacuole fusion at a ring of vertex docking sites leaves membrane fragments within the organelle. Cell. 2002; 108(3):357-69. DOI: 10.1016/s0092-8674(02)00632-3. View

16.

Reddick L, Alto N . Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol Cell. 2014; 54(2):321-8. PMC: 4023866. DOI: 10.1016/j.molcel.2014.03.010. View

17.

Costa S, Lesser C . A multifunctional region of the Shigella type 3 effector IpgB1 is important for secretion from bacteria and membrane targeting in eukaryotic cells. PLoS One. 2014; 9(4):e93461. PMC: 3981709. DOI: 10.1371/journal.pone.0093461. View

18.

Ohya K, Handa Y, Ogawa M, Suzuki M, Sasakawa C . IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J Biol Chem. 2005; 280(25):24022-34. DOI: 10.1074/jbc.M502509200. View

19.

Geddes K, Worley M, Niemann G, Heffron F . Identification of new secreted effectors in Salmonella enterica serovar Typhimurium. Infect Immun. 2005; 73(10):6260-71. PMC: 1230965. DOI: 10.1128/IAI.73.10.6260-6271.2005. View

20.

Strahl T, Thorner J . Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae. Biochim Biophys Acta. 2007; 1771(3):353-404. PMC: 1868553. DOI: 10.1016/j.bbalip.2007.01.015. View